263769-22-8 Usage
Description
(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester is a complex organic compound with a specific stereochemistry and functional groups. It is characterized by its molecular structure, which includes a piperidine ring with a methyl ester group and a chlorophenyl moiety. (3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester is primarily used as a research chemical, offering potential applications in various fields due to its unique properties.
Uses
Used in Pharmaceutical Research:
(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester is used as a research chemical for the development of new pharmaceuticals. Its unique structure and functional groups make it a valuable starting point for the synthesis of novel drug candidates, particularly in the areas of central nervous system disorders and other therapeutic applications.
Used in Chemical Synthesis:
In the field of chemical synthesis, (3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester serves as an intermediate or building block for the creation of more complex molecules. Its specific stereochemistry and functional groups can be exploited to produce a variety of compounds with potential applications in various industries.
Used in Material Science:
(3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester may also find applications in material science, where its unique properties could be utilized to develop new materials with specific characteristics. These materials could have potential uses in various industries, such as electronics, coatings, or adhesives.
Used in Analytical Chemistry:
As a research chemical, (3R,4S)-4-(4-chlorophenyl)-1-methylpiperidine-3-carboxylic acid methyl ester can be employed in analytical chemistry for the development of new methods and techniques. Its unique properties may be useful in the separation, detection, or quantification of other compounds, contributing to the advancement of analytical methodologies.
Check Digit Verification of cas no
The CAS Registry Mumber 263769-22-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 2,6,3,7,6 and 9 respectively; the second part has 2 digits, 2 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 263769-22:
(8*2)+(7*6)+(6*3)+(5*7)+(4*6)+(3*9)+(2*2)+(1*2)=168
168 % 10 = 8
So 263769-22-8 is a valid CAS Registry Number.
InChI:InChI=1/C14H18ClNO2/c1-16-8-7-12(13(9-16)14(17)18-2)10-3-5-11(15)6-4-10/h3-6,12-13H,7-9H2,1-2H3/t12-,13+/m1/s1
263769-22-8Relevant articles and documents
Process development toward the pilot scale synthesis of the piperidine-based cocaine analogue and potent dopamine and norepinephrine reuptake inhibitor CTDP 31,446
Mobele, Bingidimi I.,Kinahan, Taryn,Ulysse, Luckner G.,Gagnier, Steven V.,Ironside, Michael D.,Knox, Graham S.,Mohammadi, Farahnaz
, p. 914 - 920 (2012/12/23)
(+)-Methyl 4β-(4-chlorophenyl)-1-methylpiperidine-3α-carboxylate hydrochloride (CTDP 31,446) is known as a dopamine reuptake inhibitor. This cocaine analogue lacking the tropane skeleton is being considered for potential treatment of cocaine addiction. Herein we report the development of a scalable process for the preparation of this compound. This study was mainly aimed at improving the process throughput, eliminating chromatographic purifications for the separation of (±)-6-cis isomer from (±)-6-trans isomer, and developing a robust crystallization for isolation of pure (±)-6-cis in a single crop with a good mass recovery. The process development work also highlights an efficient recycle of (±)-6-trans via a kinetic epimerization followed by crystallization of the resulting (±)-6-cis isomer. The resolution of (±)-6-cis and the crystallization of the final HCl salt were optimized and implemented to afford CTDP-31,446 with high purity and good mass recovery.
Analogs of cocaine
-
, (2008/06/13)
The invention provides a compound of formula (I): STR1wherein R 1, R 2, R 3, and Y have any of the meanings defined in the specification; as well a pharmaceutical composition comprising a compound of formula I; intermediates and methods useful for preparing a compound of formula I; and therapeutic methods for treating drug addiction, Parkinson''s disease or depression comprising administering a compound of formula I, to a mammal in need of such treatment.
Synthesis and biological evaluation of 1-azabicyclo-[3.2.1]octanes: New dopamine transporter inhibitors
Tamiz, Amir P.,Smith, Miles P.,Enyedy, Istvan,Flippen-Anderson, Judith,Zhang, Mei,Johnson, Kenneth M.,Kozikowski, Alan P.
, p. 1681 - 1686 (2007/10/03)
The synthesis and biological activity of a series of 6-substituted 1-azabicyclo[3.2.1]octanes are described. 1-Azabicyclo[3.2.1]octanes represent a new class of compounds that exhibit monoamine transporter inhibitory activity highly dependent on the overall topology and the absolute stereochemistry of the molecule. (C) 2000 Elsevier Science Ltd. All rights reserved.